Gaois

Search direction

Search mode

Filter results

Collections

69 results in 16 documents

  1. #2694158

    Chr. Hansen 2019 agus 2021 (nár foilsíodh).

    Chr. Hansen 2019 and 2021 (unpublished).

    Commission Implementing Regulation (EU) 2023/7 of 3 January 2023 authorising the placing on the market of Lacto-N-tetraose produced by derivative strains of Escherichia coli BL21(DE3) as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

  2. #2694159

    Chr. Hansen 2020 (nár foilsíodh).

    Chr. Hansen 2020 (unpublished).

    Commission Implementing Regulation (EU) 2023/7 of 3 January 2023 authorising the placing on the market of Lacto-N-tetraose produced by derivative strains of Escherichia coli BL21(DE3) as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

  3. #2694160

    Chr. Hansen 2021 (nár foilsíodh).

    Chr. Hansen 2021 (unpublished).

    Commission Implementing Regulation (EU) 2023/7 of 3 January 2023 authorising the placing on the market of Lacto-N-tetraose produced by derivative strains of Escherichia coli BL21(DE3) as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

  4. #2694179

    Iarratasóir: “Chr. Hansen A/S”, Boege Allé 10-12, 2970 Hoersholm, an Danmhairg.

    Applicant: ‘Chr. Hansen A/S’, Boege Allé 10-12, 2970 Hoersholm, Denmark.

    Commission Implementing Regulation (EU) 2023/7 of 3 January 2023 authorising the placing on the market of Lacto-N-tetraose produced by derivative strains of Escherichia coli BL21(DE3) as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

  5. #2694371

    Chr. Hansen 2019 agus 2021 (neamhfhoilsithe).

    Chr. Hansen 2019 and 2021 (unpublished).

    Commission Implementing Regulation (EU) 2023/52 of 4 January 2023 authorising the placing on the market of 3-Fucosyllactose produced by a derivative strain of Escherichia coli BL21(DE3) as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

  6. #2694372

    Chr. Hansen 2020 (neamhfhoilsithe).

    Chr. Hansen 2020 (unpublished).

    Commission Implementing Regulation (EU) 2023/52 of 4 January 2023 authorising the placing on the market of 3-Fucosyllactose produced by a derivative strain of Escherichia coli BL21(DE3) as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

  7. #2694373

    Chr. Hansen 2021 (neamhfhoilsithe).

    Chr. Hansen 2021 (unpublished).

    Commission Implementing Regulation (EU) 2023/52 of 4 January 2023 authorising the placing on the market of 3-Fucosyllactose produced by a derivative strain of Escherichia coli BL21(DE3) as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

  8. #2694394

    Iarratasóir: ‘Chr. Hansen A/S’, Boege Allé 10-12, 2970 Hoersholm, An Danmhairg

    Applicant: “Chr. Hansen A/S”, Bøge Allé 10-12, 2970 Hørsholm, Denmark

    Commission Implementing Regulation (EU) 2023/52 of 4 January 2023 authorising the placing on the market of 3-Fucosyllactose produced by a derivative strain of Escherichia coli BL21(DE3) as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

  9. #2705530

    Chr. Hansen 2019 agus 2021 (neamhfhoilsithe).

    Chr. Hansen 2019 and 2021 (unpublished).

    Commission Implementing Regulation (EU) 2023/113 of 16 January 2023 authorising the placing on the market of 3'-Sialyllactose sodium salt produced by derivative strains of Escherichia coli BL21(DE3) as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

  10. #2705531

    Chr. Hansen 2020 (neamhfhoilsithe).

    Chr. Hansen 2020 (unpublished).

    Commission Implementing Regulation (EU) 2023/113 of 16 January 2023 authorising the placing on the market of 3'-Sialyllactose sodium salt produced by derivative strains of Escherichia coli BL21(DE3) as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

  11. #2705532

    Chr. Hansen 2021 (neamhfhoilsithe).

    Chr. Hansen 2021 (unpublished).

    Commission Implementing Regulation (EU) 2023/113 of 16 January 2023 authorising the placing on the market of 3'-Sialyllactose sodium salt produced by derivative strains of Escherichia coli BL21(DE3) as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

  12. #2705537

    Chr. Hansen 2020 agus 2021 (neamhfhoilsithe).

    Chr. Hansen 2020 and 2021 (unpublished).

    Commission Implementing Regulation (EU) 2023/113 of 16 January 2023 authorising the placing on the market of 3'-Sialyllactose sodium salt produced by derivative strains of Escherichia coli BL21(DE3) as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

  13. #2705556

    Iarratasóir: ‘Chr. Hansen A/S’, Boege Allé 10-12, 2970 Hoersholm, An Danmhairg

    Applicant: “Chr. Hansen A/S”, Boege Allé 10-12, 2970 Hoersholm, Denmark

    Commission Implementing Regulation (EU) 2023/113 of 16 January 2023 authorising the placing on the market of 3'-Sialyllactose sodium salt produced by derivative strains of Escherichia coli BL21(DE3) as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

  14. #2810689

    Chr. Hansen 2018 agus 2021 (nár foilsíodh).

    Chr. Hansen 2018 and 2021 (unpublished).

    Commission Implementing Regulation (EU) 2023/948 of 12 May 2023 authorising the placing on the market of 6'-Sialyllactose sodium salt produced by derivative strains of Escherichia coli BL21(DE3) as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

  15. #2810690

    Chr. Hansen 2021 (nár foilsíodh).

    Chr. Hansen 2021 (unpublished).

    Commission Implementing Regulation (EU) 2023/948 of 12 May 2023 authorising the placing on the market of 6'-Sialyllactose sodium salt produced by derivative strains of Escherichia coli BL21(DE3) as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

  16. #2810691

    Chr. Hansen 2020 agus 2021 (nár foilsíodh).

    Chr. Hansen 2020 and 2021 (unpublished).

    Commission Implementing Regulation (EU) 2023/948 of 12 May 2023 authorising the placing on the market of 6'-Sialyllactose sodium salt produced by derivative strains of Escherichia coli BL21(DE3) as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

  17. #2810692

    Chr. Hansen 2014 agus 2021 (nár foilsíodh).

    Chr. Hansen 2014 and 2021 (unpublished).

    Commission Implementing Regulation (EU) 2023/948 of 12 May 2023 authorising the placing on the market of 6'-Sialyllactose sodium salt produced by derivative strains of Escherichia coli BL21(DE3) as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

  18. #2810712

    Iarratasóir: ‘Chr. Hansen A/S’, Boege Allé 10-12, 2970 Hoersholm, an Danmhairg.

    Applicant: “Chr. Hansen A/S”, Bøge Allé 10-12, 2970 Hoersholm, Denmark.

    Commission Implementing Regulation (EU) 2023/948 of 12 May 2023 authorising the placing on the market of 6'-Sialyllactose sodium salt produced by derivative strains of Escherichia coli BL21(DE3) as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

  19. #2873356

    Iarratasóir: ‘Chr. Hansen A/S’, Boege Allé 10-12, 2970 Hoersholm, an Danmhairg.

    Applicant: “Chr. Hansen A/S”, Boege Allé 10-12, 2970 Hoersholm, Denmark.

    Commission Implementing Regulation (EU) 2023/1582 of 1 August 2023 amending Implementing Regulation (EU) 2017/2470 as regards the conditions of use of the novel food 3'-Sialyllactose sodium salt produced by derivative strains of Escherichia coli BL21(DE3) (Text with EEA relevance)

  20. #2694144

    Ní údaraítear ach an chuideachta Chr. Hansen A/S an bia núíosach dá dtagraítear in Airteagal 1 a chur ar an margadh laistigh den Aontas ar feadh tréimhse cúig bliana ó 24 Eanáir 2023, ach amháin má fhaigheann iarratasóir údarú ina dhiaidh sin don bhia núíosach sin gan tagairt do na sonraí eolaíocha atá á gcosaint de bhun Airteagal 3 nó le comhaontú ó Chr. Hansen A/S.

    Only the company Chr. Hansen A/S is authorised to place on the market within the Union the novel food referred to in Article 1, for a period of five years from 24 January 2023, unless a subsequent applicant obtains an authorisation for that novel food without reference to the scientific data protected pursuant to Article 3 or with the agreement of Chr. Hansen A/S.

    Commission Implementing Regulation (EU) 2023/7 of 3 January 2023 authorising the placing on the market of Lacto-N-tetraose produced by derivative strains of Escherichia coli BL21(DE3) as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

  21. #2694180

    Is é “Chr. Hansen A/S” amháin atá údaraithe chun an bia núíosach lachta-N-teatra-ós a chur ar an margadh laistigh den Aontas le linn na tréimhse cosanta sonraí, ach amháin má fhaigheann iarratasóir ina dhiaidh sin údarú i dtaobh an bhia núíosaigh gan tagairt don fhianaise eolaíoch dhílseánaigh nó do na sonraí eolaíocha atá faoi chosaint i gcomhréir le hAirteagal 26 de Rialachán (AE) 2015/2283, sin nó le comhaontú ó “Chr. Hansen A/S”.

    During the period of data protection, the novel food Lacto-N-tetraose is authorised for placing on the market within the Union only by ‘Chr. Hansen A/S’ unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of ‘Chr. Hansen A/S’.

    Commission Implementing Regulation (EU) 2023/7 of 3 January 2023 authorising the placing on the market of Lacto-N-tetraose produced by derivative strains of Escherichia coli BL21(DE3) as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

  22. #2694357

    Ní údaraítear ach an chuideachta Chr. Hansen A/S an bia núíosach dá dtagraítear in Airteagal 1 a chur ar an margadh laistigh den Aontas, ar feadh tréimhse cúig bliana ón 25 Eanáir 2023, ach amháin má fhaigheann iarratasóir údarú ina dhiaidh sin don bhia núíosach sin gan tagairt do na sonraí eolaíocha atá á gcosaint de bhun Airteagal 3 nó le comhaontú Chr. Hansen A/S.

    Only the company Chr. Hansen A/S is authorised to place on the market within the Union the novel food referred to in Article 1, for a period of five years from 25 January 2023, unless a subsequent applicant obtains an authorisation for that novel food without reference to the scientific data protected pursuant to Article 3 or with the agreement of Chr. Hansen A/S.

    Commission Implementing Regulation (EU) 2023/52 of 4 January 2023 authorising the placing on the market of 3-Fucosyllactose produced by a derivative strain of Escherichia coli BL21(DE3) as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

  23. #2694395

    Is é Chr. Hansen A/S amháin atá údaraithe chun an bia núíosach 3-fúcaishiollachtós a chur ar an margadh laistigh den Aontas le linn na tréimhse cosanta sonraí, ach amháin má fhaigheann iarratasóir ina dhiaidh sin údarú i dtaobh an bhia núíosaigh gan tagairt don fhianaise eolaíoch dhílseánaigh nó do na sonraí eolaíocha atá faoi chosaint i gcomhréir le hAirteagal 26 de Rialachán (AE) 2015/2283 nó le comhaontú ó ‘Chr. Hansen A/S’.

    During the period of data protection, the novel food 3-Fucosyllactose is authorised for placing on the market within the Union only by Chr. Hansen A/S unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of “Chr. Hansen A/S”.

    Commission Implementing Regulation (EU) 2023/52 of 4 January 2023 authorising the placing on the market of 3-Fucosyllactose produced by a derivative strain of Escherichia coli BL21(DE3) as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

  24. #2705516

    Ní údaraítear ach an chuideachta Chr. Hansen A/S an bia núíosach dá dtagraítear in Airteagal 1 a chur ar an margadh laistigh den Aontas, ar feadh tréimhse cúig bliana ó dháta theacht i bhfeidhm an Rialacháin seo an 6 Feabhra 2023, ach amháin má fhaigheann iarratasóir údarú ina dhiaidh sin don bhia núíosach sin gan tagairt do na sonraí eolaíocha atá á gcosaint de bhun Airteagal 3 nó le comhaontú Chr. Hansen A/S.

    Only the company Chr. Hansen A/S is authorised to place on the market within the Union the novel food referred to in Article 1, for a period of 5 years from 6 February 2023, unless a subsequent applicant obtains an authorisation for that novel food without reference to the scientific data protected pursuant to Article 3 or with the agreement of Chr. Hansen A/S.

    Commission Implementing Regulation (EU) 2023/113 of 16 January 2023 authorising the placing on the market of 3'-Sialyllactose sodium salt produced by derivative strains of Escherichia coli BL21(DE3) as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

  25. #2705557

    Is é Chr. Hansen A/S amháin atá údaraithe chun an bia núíosach salann sóidiam 3′-Siailiol-lachtóis a chur ar an margadh laistigh den Aontas le linn na tréimhse cosanta sonraí, ach amháin má fhaigheann iarratasóir ina dhiaidh sin údarú i dtaobh an bhia núíosaigh gan tagairt don fhianaise eolaíoch dhílseánaigh nó do na sonraí eolaíocha atá faoi chosaint i gcomhréir le hAirteagal 26 de Rialachán (AE) 2015/2283 nó le comhaontú ó ‘Chr. Hansen A/S’.

    During the period of data protection, the novel food 3′-Sialyllactose sodium salt is authorised for placing on the market within the Union only by Chr. Hansen A/S unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of “Chr. Hansen A/S”.

    Commission Implementing Regulation (EU) 2023/113 of 16 January 2023 authorising the placing on the market of 3'-Sialyllactose sodium salt produced by derivative strains of Escherichia coli BL21(DE3) as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

  26. #2810675

    Ní údaraítear ach an chuideachta Chr. Hansen A/S an bia núíosach dá dtagraítear in Airteagal 1 a chur ar an margadh laistigh den Aontas, ar feadh tréimhse cúig bliana ó dháta theacht i bhfeidhm an Rialacháin an 4 Meitheamh 2023, ach amháin má fhaigheann iarratasóir údarú ina dhiaidh sin don bhia núíosach sin gan tagairt do na sonraí eolaíocha atá faoi chosaint de bhun Airteagal 3 nó le comhaontú ó Chr. Hansen A/S.

    Only the company Chr. Hansen A/S is authorised to place on the market within the Union the novel food referred to in Article 1, for a period of five years from 4 June 2023, unless a subsequent applicant obtains an authorisation for that novel food without reference to the scientific data protected pursuant to Article 3 or with the agreement of Chr. Hansen A/S.

    Commission Implementing Regulation (EU) 2023/948 of 12 May 2023 authorising the placing on the market of 6'-Sialyllactose sodium salt produced by derivative strains of Escherichia coli BL21(DE3) as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

  27. #2810713

    Is é Chr. Hansen A/S amháin atá údaraithe chun an bia núíosach salann sóidiam 6′-Siailiol-lachtóis a chur ar an margadh laistigh den Aontas le linn na tréimhse cosanta sonraí, ach amháin má fhaigheann iarratasóir ina dhiaidh sin údarú i dtaobh an bhia núíosaigh gan tagairt don fhianaise eolaíoch dhílseánaigh nó do na sonraí eolaíocha atá faoi chosaint i gcomhréir le hAirteagal 26 de Rialachán (AE) 2015/2283 nó le comhaontú ó ‘Chr. Hansen A/S’.

    During the period of data protection, the novel food 6′-Sialyllactose sodium salt is authorised for placing on the market within the Union only by Chr. Hansen A/S unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of “Chr. Hansen A/S”.

    Commission Implementing Regulation (EU) 2023/948 of 12 May 2023 authorising the placing on the market of 6'-Sialyllactose sodium salt produced by derivative strains of Escherichia coli BL21(DE3) as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

  28. #2873357

    Is é Chr. Hansen A/S amháin atá údaraithe chun an bia núíosach salann sóidiam 3′-Siailiol-lachtóis a chur ar an margadh laistigh den Aontas le linn na tréimhse cosanta sonraí, ach amháin má fhaigheann iarratasóir ina dhiaidh sin údarú i dtaobh an bhia núíosaigh gan tagairt don fhianaise eolaíoch dhílseánaigh nó do na sonraí eolaíocha atá faoi chosaint i gcomhréir le hAirteagal 26 de Rialachán (AE) 2015/2283 nó le comhaontú ó ‘Chr. Hansen A/S’.

    During the period of data protection, the novel food 3′-Sialyllactose sodium salt is authorised for placing on the market within the Union only by Chr. Hansen A/S unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of “Chr. Hansen A/S”.

    Commission Implementing Regulation (EU) 2023/1582 of 1 August 2023 amending Implementing Regulation (EU) 2017/2470 as regards the conditions of use of the novel food 3'-Sialyllactose sodium salt produced by derivative strains of Escherichia coli BL21(DE3) (Text with EEA relevance)

  29. #2105333

    Beinsi[a]piréin (BaP), Beinsi[e]piréin (BeP), Beinsea[a]antraicéin (BaA), Criséin (CHR), Beinsea[b]fluaraintéin (BbFA), Beinsea[j]fluaraintéin (BjFA), Beinsea(k)fluaraintéin [BkFA), Dibeinsi[a,h]antraicéin (DBAhA).

    Benzo[a]pyrene (BaP), Benzo[e]pyrene (BeP), Benzo[a]anthracene (BaA), Chrysene (CHR), Benzo[b]fluoranthene (BbFA), Benzo[j]fluoranthene (BjFA), Benzo[k]fluoranthene [BkFA), Dibenzo[a,h]anthracene (DBAhA).

    Commission Regulation (EU) 2021/1199 of 20 July 2021 amending Annex XVII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council as regards polycyclic-aromatic hydrocarbons (PAHs) in granules or mulches used as infill material in synthetic turf pitches or in loose form on playgrounds or in sport applications (Text with EEA relevance)

  30. #2694223

    Chr. Hansen 2018 (nár foilsíodh) agus Parschat K., Oehme A., Leuschner J., Jennewein S., agus Parkot J. 2020.

    Chr. Hansen 2018 (unpublished) and Parschat K., Oehme A., Leuschner J., Jennewein S., and Parkot J. 2020.

    Commission Implementing Regulation (EU) 2023/7 of 3 January 2023 authorising the placing on the market of Lacto-N-tetraose produced by derivative strains of Escherichia coli BL21(DE3) as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

  31. #2694224

    Chr. Hansen 2018 agus 2021 (nár foilsíodh) agus Parschat K., Oehme A., Leuschner J., Jennewein S., agus Parkot J. 2020.

    Chr. Hansen 2018 and 2021 (unpublished) and Parschat K., Oehme A., Leuschner J., Jennewein S., and Parkot J. 2020.

    Commission Implementing Regulation (EU) 2023/7 of 3 January 2023 authorising the placing on the market of Lacto-N-tetraose produced by derivative strains of Escherichia coli BL21(DE3) as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

  32. #2694225

    Chr. Hansen 2019 agus 2021 (nár foilsíodh) agus Parschat K., Oehme A., Leuschner J., Jennewein S., agus Parkot J. 2020.

    Chr. Hansen 2019 and 2021 (unpublished) and Parschat K., Oehme A., Leuschner J., Jennewein S., and Parkot J. 2020.

    Commission Implementing Regulation (EU) 2023/7 of 3 January 2023 authorising the placing on the market of Lacto-N-tetraose produced by derivative strains of Escherichia coli BL21(DE3) as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

  33. #2694374

    Chr. Hansen 2019 agus 2021 (neamhfhoilsithe) agus Parschat K., Oehme A., Leuschner J., Jennewein S., agus Parkot J. 2020.

    Chr. Hansen 2019 and 2021 (unpublished) and Parschat K., Oehme A., Leuschner J., Jennewein S., and Parkot J. 2020.

    Commission Implementing Regulation (EU) 2023/52 of 4 January 2023 authorising the placing on the market of 3-Fucosyllactose produced by a derivative strain of Escherichia coli BL21(DE3) as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

  34. #2694442

    Chr. Hansen 2018 (neamhfhoilsithe) agus Parschat K., Oehme A., Leuschner J., Jennewein S., agus Parkot J. 2020.

    Chr. Hansen 2018 (unpublished) and Parschat K., Oehme A., Leuschner J., Jennewein S., and Parkot J. 2020.

    Commission Implementing Regulation (EU) 2023/52 of 4 January 2023 authorising the placing on the market of 3-Fucosyllactose produced by a derivative strain of Escherichia coli BL21(DE3) as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

  35. #2694443

    Chr. Hansen 2018 agus 2021 (neamhfhoilsithe) agus Parschat K., Oehme A., Leuschner J., Jennewein S., agus Parkot J. 2020.

    Chr. Hansen 2018 and 2021 (unpublished) and Parschat K., Oehme A., Leuschner J., Jennewein S., and Parkot J. 2020.

    Commission Implementing Regulation (EU) 2023/52 of 4 January 2023 authorising the placing on the market of 3-Fucosyllactose produced by a derivative strain of Escherichia coli BL21(DE3) as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

  36. #2705533

    Chr. Hansen 2018 (neamhfhoilsithe) agus Parschat K., Oehme A., Leuschner J., Jennewein S., agus Parkot J. 2020.

    Chr. Hansen 2018 (unpublished) and Parschat K., Oehme A., Leuschner J., Jennewein S., and Parkot J. 2020.

    Commission Implementing Regulation (EU) 2023/113 of 16 January 2023 authorising the placing on the market of 3'-Sialyllactose sodium salt produced by derivative strains of Escherichia coli BL21(DE3) as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

  37. #2705535

    Chr. Hansen 2018 agus 2021 (neamhfhoilsithe) agus Parschat K., Oehme A., Leuschner J., Jennewein S., agus Parkot J. 2020.

    Chr. Hansen 2018 and 2021 (unpublished) and Parschat K., Oehme A., Leuschner J., Jennewein S., and Parkot J. 2020.

    Commission Implementing Regulation (EU) 2023/113 of 16 January 2023 authorising the placing on the market of 3'-Sialyllactose sodium salt produced by derivative strains of Escherichia coli BL21(DE3) as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

  38. #2705536

    Chr. Hansen 2019 agus 2021 (neamhfhoilsithe) agus Parschat K., Oehme A., Leuschner J., Jennewein S., agus Parkot J. 2020.

    Chr. Hansen 2019 and 2021 (unpublished) and Parschat K., Oehme A., Leuschner J., Jennewein S., and Parkot J. 2020.

    Commission Implementing Regulation (EU) 2023/113 of 16 January 2023 authorising the placing on the market of 3'-Sialyllactose sodium salt produced by derivative strains of Escherichia coli BL21(DE3) as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

  39. #2810759

    Chr. Hansen 2018 (nár foilsíodh) agus Parschat K., Oehme A., Leuschner J., Jennewein S., agus Parkot J. 2020.

    Chr. Hansen 2018 (unpublished) and Parschat K., Oehme A., Leuschner J., Jennewein S., and Parkot J. 2020.

    Commission Implementing Regulation (EU) 2023/948 of 12 May 2023 authorising the placing on the market of 6'-Sialyllactose sodium salt produced by derivative strains of Escherichia coli BL21(DE3) as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

  40. #2810760

    Chr. Hansen 2018 agus 2021 (nár foilsíodh) agus Parschat K., Oehme A., Leuschner J., Jennewein S., agus Parkot J. 2020.

    Chr. Hansen 2018 and 2021 (unpublished) and Parschat K., Oehme A., Leuschner J., Jennewein S., and Parkot J. 2020.

    Commission Implementing Regulation (EU) 2023/948 of 12 May 2023 authorising the placing on the market of 6'-Sialyllactose sodium salt produced by derivative strains of Escherichia coli BL21(DE3) as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

  41. #2810761

    Chr. Hansen 2019 agus 2021 (nár foilsíodh) agus Parschat K., Oehme A., Leuschner J., Jennewein S., agus Parkot J. 2020.

    Chr. Hansen 2019 and 2021 (unpublished) and Parschat K., Oehme A., Leuschner J., Jennewein S., and Parkot J. 2020.

    Commission Implementing Regulation (EU) 2023/948 of 12 May 2023 authorising the placing on the market of 6'-Sialyllactose sodium salt produced by derivative strains of Escherichia coli BL21(DE3) as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

  42. #2068576

    An 23 Meitheamh 2019, chuir an chuideachta Chr. Hansen A/S (“an t-iarratasóir”) iarratas faoi bhráid an Choimisiúin i gcomhréir le hAirteagal 10(1) de Rialachán (AE) 2015/2283 ar údarú Lachta-N-neoiteatrós (foinse mhiocróbach) arna tháirgeadh le comhghníomhaíocht na dtréithchineálacha díorthacha PS-LNnT-JBT agus DS-LNnT-JBT de Escherichia coli, tréithchineál BL21(DE3), mar bhia núíosach faoi na coinníollacha úsáide céanna a bhaineann leis na cinn atá údaraithe faoi láthair le haghaidh Lachta-N-neoiteatrós atá sintéiseach nó a fhaightear as foinse mhiocróbach.

    On 23 June 2019, the company Chr. Hansen A/S (‘the applicant’) submitted an application to the Commission in accordance with Article 10(1) of Regulation (EU) 2015/2283 for the authorisation of Lacto-N-neotetraose (microbial source) produced by the combined activity of the derivative strains PS-LNnT-JBT and DS-LNnT-JBT of Escherichia coli strain BL21(DE3) as a novel food under the same conditions of use as the ones currently authorised for synthetic and microbial sourced Lacto-N-neotetraose.

    Commission Implementing Regulation (EU) 2021/912 of 4 June 2021 authorising changes in the specifications of the novel food Lacto-N-neotetraose (microbial source) and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

  43. #2306208

    lena gceartaítear Rialachán Cur Chun Feidhme (AE) 2020/1760 maidir le hullmhóid Bacillus subtilis DSM 25841 a údarú mar bhreiseán beatha le haghaidh gach speicis mhucúil, cránacha san áireamh, seachas cránacha atá ag tál ionas go rachaidh sé chun tairbhe do bhainbh diúil (sealbhóir údarú Chr. Hansen A/S)

    correcting Implementing Regulation (EU) 2020/1760 concerning the authorisation of the preparation of Bacillus subtilis DSM 25841 as a feed additive for all porcine species, including sows, other than lactating sows in order to have a benefit in suckling piglets (holder of authorisation Chr. Hansen A/S)

    Commission Implementing Regulation (EU) 2022/271 of 23 February 2022 correcting Implementing Regulation (EU) 2020/1760 concerning the authorisation of the preparation of Bacillus subtilis DSM 25841 as a feed additive for all porcine species, including sows, other than lactating sows in order to have a benefit in suckling piglets (holder of authorisation Chr. Hansen A/S) (Text with EEA relevance)

  44. #2306234

    Rialachán Cur Chun Feidhme (AE) 2020/1760 ón gCoimisiún an 25 Samhain 2020 maidir le hullmhóid Bacillus subtilis DSM 25841 a údarú mar bhreiseán beatha le haghaidh gach speicis mhucúil, cránacha san áireamh, seachas cránacha atá ag tál ionas go rachaidh sé chun tairbhe do bhainbh diúil (sealbhóir údarú Chr. Hansen A/S) (IO L 397, 26.11.2020, lch. 6).

    Commission Implementing Regulation (EU) 2020/1760 of 25 November 2020 concerning the authorisation of the preparation of Bacillus subtilis DSM 25841 as a feed additive for all porcine species, including sows, other than lactating sows in order to have a benefit in suckling piglets (holder of authorisation Chr. Hansen A/S) (OJ L 397, 26.11.2020, p. 6).

    Commission Implementing Regulation (EU) 2022/271 of 23 February 2022 correcting Implementing Regulation (EU) 2020/1760 concerning the authorisation of the preparation of Bacillus subtilis DSM 25841 as a feed additive for all porcine species, including sows, other than lactating sows in order to have a benefit in suckling piglets (holder of authorisation Chr. Hansen A/S) (Text with EEA relevance)

  45. #2659577

    Rialachán Cur Chun Feidhme (AE) 2022/271 ón gCoimisiún an 23 Feabhra 2022 lena gceartaítear Rialachán Cur Chun Feidhme (AE) 2020/1760 maidir le hullmhóid Bacillus subtilis DSM 25841 a údarú mar bhreiseán beatha le haghaidh gach speicis mhucúil, cránacha san áireamh, seachas cránacha atá ag tál ionas go rachaidh sé chun tairbhe do bhainbh diúil (sealbhóir an údaraithe Chr. Hansen A/S), tá sé le hionchorprú i gComhaontú LEE.

    Commission Implementing Regulation (EU) 2022/271 of 23 February 2022 correcting Implementing Regulation (EU) 2020/1760 concerning the authorisation of the preparation of Bacillus subtilis DSM 25841 as a feed additive for all porcine species, including sows, other than lactating sows in order to have a benefit in suckling piglets (holder of authorisation Chr. Hansen A/S) is to be incorporated into the EEA Agreement.

    Decision of the EEA Joint Committee No 203/2022 of 8 July 2022 amending Annex I (Veterinary and phytosanitary matters) to the EEA Agreement [2023/620]

  46. #2694117

    An 22 Bealtaine 2020, chuir an chuideachta Chr. Hansen A/S (“an t-iarratasóir”) iarratas ar údarú faoi bhráid an Choimisiúin i gcomhréir le hAirteagal 10(1) de Rialachán (AE) 2015/2283 chun lachta-N-teatra-ós (“LNT”), a fhaightear trí choipeadh miocróbach trí úsáid á baint as dhá thréithchineál ghéinmhodhnaithe (tréithchineál táirgthe agus tréithchineál díghrádúcháin roghnach) a dhíorthaítear ón tréithchineál óstach E. coli BL21(DE3), a chur ar mhargadh an Aontais mar bhia núíosach.

    On 22 May 2020, the company Chr. Hansen A/S (‘the applicant’) submitted an application for an authorisation to the Commission in accordance with Article 10(1) of Regulation (EU) 2015/2283 to place lacto-N-tetraose (‘LNT’), obtained by microbial fermentation using two genetically modified strains (a production strain and an optional degradation strain) derived from the host strain E. coli BL21(DE3), on the Union market as a novel food.

    Commission Implementing Regulation (EU) 2023/7 of 3 January 2023 authorising the placing on the market of Lacto-N-tetraose produced by derivative strains of Escherichia coli BL21(DE3) as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

  47. #2694146

    Na sonraí eolaíocha atá sa chomhad iarratais agus a chomhlíonann na coinníollacha a leagtar síos in Airteagal 26(2) de Rialachán (AE) 2015/2283, ní úsáidfear iad chun tairbhe iarratasóra ina dhiaidh sin ar feadh tréimhse cúig bliana ó dháta theacht i bhfeidhm an Rialacháin seo gan comhaontú ó Chr. Hansen A/S.

    The scientific data contained in the application file and fulfilling the conditions laid down in Article 26(2) of Regulation (EU) 2015/2283 shall not be used for the benefit of a subsequent applicant for a period of five years from the date of entry into force of this Regulation without the agreement of Chr. Hansen A/S.

    Commission Implementing Regulation (EU) 2023/7 of 3 January 2023 authorising the placing on the market of Lacto-N-tetraose produced by derivative strains of Escherichia coli BL21(DE3) as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

  48. #2694330

    An 17 Márta 2020, chuir an chuideachta Chr. Hansen A/S (“an t-iarratasóir”) iarratas ar údarú faoi bhráid an Choimisiúin i gcomhréir le hAirteagal 10(1) de Rialachán (AE) 2015/2283 chun 3-fúcaishiollachtóis (“3-FL”), rud a fhaightear trí choipeadh miocróbach agus úsáid á baint as an tréithchineál géinmhodhnaithe amháin de E. coli BL21(DE3), a chur ar mhargadh an Aontais mar bhia núíosach.

    On 17 March 2020, the company Chr. Hansen A/S (‘the applicant’) submitted an application for an authorisation to the Commission in accordance with Article 10(1) of Regulation (EU) 2015/2283 to place 3-fucosyllactose (‘3-FL’) obtained by microbial fermentation using one genetically modified strain of E. coli BL21(DE3), on the Union market as a novel food.

    Commission Implementing Regulation (EU) 2023/52 of 4 January 2023 authorising the placing on the market of 3-Fucosyllactose produced by a derivative strain of Escherichia coli BL21(DE3) as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

  49. #2694359

    Na sonraí eolaíocha atá sa chomhad iarratais agus a chomhlíonann na coinníollacha a leagtar síos in Airteagal 26(2) de Rialachán (AE) 2015/2283, ní úsáidfear iad chun tairbhe iarratasóra ina dhiaidh sin ar feadh tréimhse cúig bliana ó dháta theacht i bhfeidhm an Rialacháin seo gan comhaontú Chr. Hansen A/S.

    The scientific data contained in the application file and fulfilling the conditions laid down in Article 26(2) of Regulation (EU) 2015/2283 shall not be used for the benefit of a subsequent applicant for a period of five years from the date of entry into force of this Regulation without the agreement of Chr. Hansen A/S.

    Commission Implementing Regulation (EU) 2023/52 of 4 January 2023 authorising the placing on the market of 3-Fucosyllactose produced by a derivative strain of Escherichia coli BL21(DE3) as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)

  50. #2705489

    An 13 Bealtaine 2020, chuir an chuideachta Chr. Hansen A/S (“an t-iarratasóir”) iarratas ar údarú faoi bhráid an Choimisiúin i gcomhréir le hAirteagal 10(1) de Rialachán (AE) 2015/2283 chun salann sóidiam 3’-Siailiol-lachtóis (‘3’-SL’), rud a fhaightear trí choipeadh miocróbach ina n-úsáidtear dhá thréithchineál ghéinmhodhnaithe (tréithchineál táirgthe agus tréithchineál díghrádúcháin roghnach) a dhíorthaítear ón tréithchineál óstach E. coli BL21(DE3), a chur ar mhargadh an Aontais mar bhia núíosach.

    On 13 May 2020, the company Chr. Hansen A/S (‘the applicant’) submitted an application for an authorisation to the Commission in accordance with Article 10(1) of Regulation (EU) 2015/2283 to place 3′-Sialyllactose (‘3′-SL’) sodium salt, obtained by microbial fermentation using two genetically modified strains (a production strain and an optional degradation strain) derived from the host strain E. coli BL21(DE3), on the Union market as a novel food.

    Commission Implementing Regulation (EU) 2023/113 of 16 January 2023 authorising the placing on the market of 3'-Sialyllactose sodium salt produced by derivative strains of Escherichia coli BL21(DE3) as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)